7.4 Palliative Nutrition & Goals of Care Alignment

7.4 Palliative Nutrition & Goals of Care Alignment

Quick Summary: As cancer advances to terminal stages where curative treatments are no longer effective or feasible, the goals of medical nutrition therapy undergo a fundamental transformation. Palliative nutrition care is defined as nutrition support provided to individuals with life-limiting disease where the primary objective is to enhance quality of life (QoL), relieve burdensome symptoms, minimize psychological distress, and honor patient autonomy. Understanding the stages of cancer cachexia and communicating effectively with patients and families are essential skills for the Board Certified Specialist in Oncology Nutrition (CSO).

---

1. The Cancer Cachexia Continuum & The Refractory Phase

Cancer cachexia is a multi-factorial syndrome characterized by ongoing loss of skeletal muscle mass (with or without loss of fat mass) that cannot be fully reversed by conventional nutritional support and leads to progressive functional impairment. The international consensus framework defines three clinical stages of cancer cachexia:

+-----------------------------------------------------------------------------------+
|                         STAGES OF CANCER CACHEXIA                                 |
+----------------------+-----------------------+------------------------------------+
| Stage                | Clinical Diagnostic Criteria                          |
+----------------------+-----------------------+------------------------------------+
| 1. Precachexia       | Weight loss <=5%; early systemic inflammation; anorexia and|
|                      | glucose intolerance present before major muscle loss.      |
| 2. Cachexia          | Weight loss >5% (or BMI <20 kg/m² with weight loss >2%, or |
|                      | appendicular muscle depletion with weight loss >2%);       |
|                      | reduced food intake and systemic inflammation.             |
| 3. Refractory        | Proactive cancer therapy no longer active/possible; highly |
|    Cachexia          | catabolic state; life expectancy < 3 months; un-responsive |
|                      | to artificial nutrition; rapid functional decline.          |
+----------------------+-----------------------+------------------------------------+

Clinical Reality of Refractory Cachexia

In refractory cachexia, tumor-derived catabolic factors (such as Proteolysis-Inducing Factor [PIF] and Lipid-Mobilizing Factor [LMF]) alongside overwhelming systemic cytokines (TNF-$\alpha$, IL-6, IFN-$\gamma$) alter normal metabolic pathways. Skeletal muscle protein synthesis is blunted while ubiquitin-proteasome degradation is hyper-activated. Consequently, administering high-calorie enteral or parenteral nutrition in this phase does not translate into lean muscle mass gain, improved performance status, or extended survival, but rather increases fluid overload and physical discomfort.

---

2. Shifting the Goals of Care

The fundamental clinical shift between curative/restorative nutrition care and palliative nutrition care is outlined below:

---

3. Targeted Palliative Symptom Management

During advanced cancer, oral intake is frequently compromised by distressing symptoms. The oncology dietitian implements targeted, practical strategies to minimize symptom burden:

+-----------------------------------------------------------------------------------+
|                    TARGETED PALLIATIVE SYMPTOM MANAGEMENT                         |
+-----------------------+-----------------------------------------------------------+
| Symptom               | Practical Evidence-Based Interventions                    |
+-----------------------+-----------------------------------------------------------+
| Anorexia & Early      | - Provide small, frequent meals/snacks (bite-sized foods). |
| Satiety               | - Serve food on small dessert plates to avoid feeling     |
|                       |   overwhelmed by large portions.                          |
|                       | - Encourage high-nutrient density items when hungry.      |
|                       | - Avoid drinking fluids *with* meals to prevent fullness. |
|                       | - Offer room-temperature or cold foods (less aroma).      |
+-----------------------+-----------------------------------------------------------+
| Xerostomia            | - Provide frequent oral hygiene and soft water swabs.     |
| (Dry Mouth)           | - Moisten foods with gravies, sauces, broths, or butter.  |
|                       | - Use artificial saliva sprays or oral rinses.            |
|                       | - Offer frozen ice chips, popsicles, or sour candies      |
|                       |   (if mucosa intact) to stimulate salivary flow.          |
+-----------------------+-----------------------------------------------------------+
| Dysgeusia             | - Use plastic or bamboo utensils if metallic taste occurs.|
| (Taste Alterations)   | - Marinate meats/proteins in acidic juices (lemon, lime)  |
|                       |   or sweet marinades to mask bitter tones.                |
|                       | - Add strong seasonings, herbs, or tart flavors as liked. |
|                       | - Avoid canned foods or metal cookware.                   |
+-----------------------+-----------------------------------------------------------+
| Nausea & Odor         | - Avoid cooking odors; prepare food in well-ventilated    |
| Sensitivity           |   areas away from the patient.                            |
|                       | - Serve cold or room-temperature foods (bland items).     |
|                       | - Administer antiemetics (e.g., ondansetron) 30 min prior |
|                       |   to offered meals.                                       |
+-----------------------+-----------------------------------------------------------+
| Dyspnea               | - Offer soft, moist foods requiring minimal chewing.      |
| (Shortness of Breath) | - Coordinate meal times after bronchodilators/oxygen use. |
|                       | - Position patient in an upright, seated posture (90°).   |
+-----------------------+-----------------------------------------------------------+

Pharmacotherapy Considerations in Palliative Care

Orexigenic agents may be considered for short-term appetite stimulation in palliative cancer patients:

• Corticosteroids (Dexamethasone 2-4 mg/day): Rapidly improves appetite and sense of well-being within days. Ideal for patients with life expectancy measured in weeks due to long-term side effects (myopathy, hyperglycemia, immunosuppression).
• Progestins (Megestrol Acetate 400-800 mg/day): Increases appetite and body weight (primarily fat mass and fluid retention). Caution: Significantly increases deep vein thrombosis (DVT) and pulmonary embolism risk.

---

4. Caregiver Education & Re-framing the "Starvation Myth"

One of the most emotionally challenging aspects of advanced cancer care is the profound distress experienced by family members as they observe their loved one eating progressively less. In many cultures, providing food is synonymous with love, care, and preserving life. Families frequently equate declining intake with "giving up" or fear that the patient is suffering from painful starvation.

CAREGIVER DISTRESS: "My family member is starving to death!"
       │
       v
CLINICAL RE-FRAMING & COUNSELING BY ONCOLOGY DIETITIAN:
  1. Explaining Physiology: Anorexia is a natural result of terminal illness,
     not the cause of dying.
  2. Reassuring Comfort: Dehydration and reduced intake at EOL release endogenous
     endorphins, creating a natural anesthetic effect.
  3. Stopping Forced Feeding: Pressuring patients to eat causes nausea, vomiting,
     bloating, and distress.
  4. Re-directing Care: Shift focus from feeding to non-nutritional care (hand massages,
     oral moistening, reading, presence).

Key Educational Points for Families:

1. Anorexia is a Symptom of Disease Progression: Explain that the body is naturally shutting down its digestive machinery and that reduced appetite is a protective physiological response, not painful starvation.
2. Harm of Forced Feeding: Forcing or coercing a terminal patient to eat can precipitate severe physical discomfort, including distension, early satiety, nausea, vomiting, gastroesophageal reflux, and aspiration.
3. Alternative Expressions of Care: Encourage families to express love through non-food interactions, such as providing gentle mouth care with moist swabs, applying lip balm, sitting together, playing music, or offering gentle hand/foot massages.